James P. Shaffer
2013
In 2013, James P. Shaffer earned a total compensation of $1.1M as Former Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $293,336 |
|---|---|
| Option Awards | $199,785 |
| Salary | $366,670 |
| Stock Awards | $196,500 |
| Other | $44,221 |
| Total | $1,100,512 |
Shaffer received $366.7K in salary, accounting for 33% of the total pay in 2013.
Shaffer also received $293.3K in non-equity incentive plan, $199.8K in option awards, $196.5K in stock awards and $44.2K in other compensation.
Rankings
In 2013, James P. Shaffer's compensation ranked 6,185th out of 12,286 executives tracked by ExecPay. In other words, Shaffer earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,185 out of 12,286 | 50th |
Division Manufacturing | 2,155 out of 4,612 | 53rd |
Major group Chemicals And Allied Products | 638 out of 1,466 | 57th |
Industry group Drugs | 461 out of 1,160 | 60th |
Industry Biological Products, Except Diagnostic Substances | 72 out of 200 | 64th |
Source: SEC filing on April 3, 2015.
Shaffer's colleagues
We found five more compensation records of executives who worked with James P. Shaffer at Halozyme Therapeutics in 2013.
2013
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2013
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2013
Jean Liu
Halozyme Therapeutics
General Counsel
2013
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2013
Kurt Gustafson
Halozyme Therapeutics